8 March 2022
Rotork plc ('Company')
Notification of transactions by Persons Discharging Managerial Responsibilities ('PDMRs')
The Company provides notification of the following transaction, effected on 7 March 2022 outside of a market venue, relating to the below named Executive Director and his respective interests in the ordinary share capital of the Company (ISIN: GB00BVFNZH21).
The transaction arises from the vesting of a conditional award over shares granted to Jonathan Davis on 5 March 2019 under the Company's Deferred Annual Bonus Plan relating to the three-year deferred element of his 2018 annual bonus (and subsequent dealing to discharge the tax and social security liability arising, with Mr Davis retaining the balance of the shares vesting).
| Name and position of PDMR | No. of shares acquired on vesting, sold and retained on 7 March 2022 as above
|
| Jonathan Davis, Group Finance Director
| 38,987 shares acquired (including 2,197 dividend equivalents) |
| 18,324 shares sold at GBP 2.852 per share(i) | |
| 20,663 shares retained(ii) |
| (i) | The shares sold were to cover Jonathan Davis' income tax and social security liability arising on vesting. The shares sold were purchased by Rotork's Employee Benefit Trust at the price of GBP 2.852 per share, being the closing price for a share on 4 March 2022. |
| (ii) | The net shares retained are held in the name of Jonathan Davis' spouse, a Person Closely Associated with him as defined under the Market Abuse Regulations ('MAR'). |
The Company can confirm that the above named PDMR has complied with his obligation to notify the Financial Conduct Authority of the above transactions as required under MAR.
- END -
Rotork contact and telephone number for enquiries:
Stuart Pain, Group General Counsel & Company Secretary Tel: +44 (0)1225 733 200
Notes:
Legal Entity Identifier: 213800AH5RZIHGWRJ718
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
